HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinicopathologic and prognostic values of apolipoprotein D alterations in hepatocellular carcinoma.

Abstract
We previously identified apolipoprotein D (Apo D) as a novel tumor suppressor gene based on the pharmacological unmasking of epigenetic silencing. We analyzed Apo D expression using real-time reverse transcription-PCR and evaluated its expression status based on the clinicopathological parameters of 70 patients with hepatocellular carcinoma (HCC). Immunohistochemical staining was also performed. We determined the methylation status of Apo D gene promoter by methylation-specific PCR (MSP). The Apo D gene-expression in tumor tissue was significantly lower than that in nontumor tissue (p = 0.011). A low Apo D expression significantly correlated with less-differentiated HCC (p = 0.019). Immunohistochemical studies confirmed a decreased Apo D expression in poorly differentiated tumors. The prognosis of patients with a lower Apo D gene-expression was significantly worse than that in those with a higher expression (p = 0.028). The Apo D gene-expression was an independent prognostic factor (relative risk: 2.36, p = 0.018). An MSP assay showed a low-level of methylation in well differentiated HCC and a high-level of methylation in less differentiated tumors. Apo D may be a novel tumor suppressor gene of HCC, and its expression status may be a useful biomarker for predicting the patient outcome.
AuthorsTohru Utsunomiya, Kazuhiko Ogawa, Keiji Yoshinaga, Mitsuhiko Ohta, Keishi Yamashita, Koshi Mimori, Hiroshi Inoue, Takahiro Ezaki, Yasuji Yoshikawa, Masaki Mori
JournalInternational journal of cancer (Int J Cancer) Vol. 116 Issue 1 Pg. 105-9 (Aug 10 2005) ISSN: 0020-7136 [Print] United States
PMID15756681 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Copyright(c) 2005 Wiley-Liss, Inc.
Chemical References
  • Apolipoproteins
  • Apolipoproteins D
  • RNA, Messenger
  • Azacitidine
Topics
  • Aged
  • Apolipoproteins (genetics)
  • Apolipoproteins D
  • Azacitidine (pharmacology)
  • Carcinoma, Hepatocellular (genetics, mortality, pathology)
  • DNA Methylation
  • Female
  • Gene Silencing
  • Genes, Tumor Suppressor
  • Humans
  • Liver Neoplasms (genetics, mortality, pathology)
  • Male
  • Middle Aged
  • Prognosis
  • Promoter Regions, Genetic
  • RNA, Messenger (analysis)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Survival Analysis
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: